Since ERα gene expression is regulated by methylation (Frick, 2015), a recent clinical study examined whether the methylation level of the promoter of the ERα gene and its protein expression correlated with changes in cognitive function and quality of daily living in AD. This evidence concerns the gene ESR1 and Alzheimer disease.